In the current work, we measure the performance of seven ligand-based virtual screening tools - five similarity search methods and two pharmacophore elucidators - against the MUV data set. For the similarity search tools, single active molecules as well as active compound sets clustered in terms of their chemical diversity were used as templates. Their score was calculated against all inactive and active compounds in their target class. Subsequently, the scores were used to calculate different performance metrics including enrichment factors and AUC values. We also studied the effect of data fusion on the results. To measure the performance of the pharmacophore tools, a set of active molecules was picked either random- or chemical diversity...
In recent years, many virtual screening (VS) tools have been developed that employ different molecul...
Data fusion is being increasingly used to combine the outputs of different types of sensor. This pa...
AbstractDeveloping new medical drugs is expensive. Among the first steps is a screening process, in ...
In the current work, we measure the performance of seven ligand-based virtual screening tools - five...
In the current work, we measure the performance of seven ligand-based virtual screening tools - five...
In the current work, we measure the performance of seven ligand-based virtual screening tools - five...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
Item does not contain fulltextThe pharmacophore concept is of central importance in computer-aided d...
Virtual screening is a well-established part of computer-aided drug design, which heavily employs si...
The pharmacophore concept is of central importance in computer-aided drug design (CADD) mainly becau...
Virtual screening emerged as an important tool in our quest to access novel drug like compounds. The...
During the past decade, virtual screening (VS) has evolved from traditional similarity searching, wh...
In recent years, many virtual screening (VS) tools have been developed that employ different molecul...
Data fusion is being increasingly used to combine the outputs of different types of sensor. This pa...
AbstractDeveloping new medical drugs is expensive. Among the first steps is a screening process, in ...
In the current work, we measure the performance of seven ligand-based virtual screening tools - five...
In the current work, we measure the performance of seven ligand-based virtual screening tools - five...
In the current work, we measure the performance of seven ligand-based virtual screening tools - five...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
The pharmacophore concept is of central importance in computer-aided drug design (GADD) mainly becau...
Item does not contain fulltextThe pharmacophore concept is of central importance in computer-aided d...
Virtual screening is a well-established part of computer-aided drug design, which heavily employs si...
The pharmacophore concept is of central importance in computer-aided drug design (CADD) mainly becau...
Virtual screening emerged as an important tool in our quest to access novel drug like compounds. The...
During the past decade, virtual screening (VS) has evolved from traditional similarity searching, wh...
In recent years, many virtual screening (VS) tools have been developed that employ different molecul...
Data fusion is being increasingly used to combine the outputs of different types of sensor. This pa...
AbstractDeveloping new medical drugs is expensive. Among the first steps is a screening process, in ...